Governance of Human Genome Editing and the Role of Interdisciplinary Collaborations

Authors

    Kazuto Kato Department of Biomedical Ethics and Public Policy, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan

Keywords:

Genome editing, Genetic modification passed on to next generations, Scientific research community, World Health Organisation, Interdisciplinary collaboration

Abstract

Making possible the easy and effective modification of genes, genome editing has become an indispensable tool for basic and applied medicine and life sciences. Since 2015, when a research paper describing basic research work on genome editing in human embryos was published, there has been extensive discussion on the use of the technology in humans. In particular, the question regarding whether the technology can be applied to the human germ line through which modified genes are passed on to the next generations has been hotly debated. In this article, by analyzing various events and discourses during this period, some crucial issues and lessons for the future have been highlighted and examined. During the analysis, it became clear that, while the scientific community played an important role in stimulating public discussions, its self-regulation was not sufficient to prevent incidents like the birth of twin babies through genome editing. In the future, it will be crucial to deepen more interdisciplinary and global-scale discussions through the participation of non-medical and scientific specialists, citizens, patients, etc. Bioethicists and ELSI (Ethical, Legal, and Social Issues or Implications) specialists are also expected to play an important role in facilitating such discussions.

References

Mashita T, Kaneda Y. Genome Editing for Medical Applications. 2018, Kinokuniya Shoten, Tokyo.

Statement on the Announcement of the Birth of Twins from Human Fertilised Eggs by Genome Editing Technology, Directors of the Japanese Association for Bioethics, 2018, Tokyo.

Kato K. Genomics, Society and Ethics. In Development of Genome Science, Chapter 5. 2011, Iwanami Shoten, Tokyo.

United Nations Educational, Scientific and Cultural Organization (UNESCO). Universal Declaration on the Human Genome and Human Rights. 1997, Paris.

Liang P, Xu Y, Zhang X, et al., 2015, CRISPR/Cas9-Mediated Gene Editing in Human Tripronuclear Zygotes. Protein Cell, 6(5): 363–372.

Japan Council for Science, Technology and Innovation, Expert Committee on Bioethics. Research Using Genome Editing Technology on Human Fertilised Embryos (Interim Summary). 2016, Tokyo.

Committee on Science, Technology and Law, Policy and Global Affairs, National Academies of Sciences, Engineering, and Medicine, et al. International Summit on Human Gene Editing: A Global Discussion. Meeting in Brief 2015. 2016, National Academic Press (US), Washington.

Greely HT, 2019, CRISPR’d Babies: Human Germline Genome Editing in the ‘He Jiankui Affair’. Journal of Law and the Biosciences, 6(1): 111–183.

Kato K, 2019, Ethical Issues and Governance of Genome Editing on Human Subjects. Law and Technology, 84: 77–88.

Kato K, Kokado M, Hamakawa N, 2020, Regulatory Trends in Genome Editing of Human Fertilised Embryos. Igakuno Ayumi, 273(9): 902–908.

FY 2019 Health and Labour Science Special Research Project “Research on the Legal Systems and Latest Trends Related to the Handling of Human Embryos Using Genome Editing Technology, etc. in Other Countries and on the Ideal Japanese Public Regulations” (Principal Investigator: Kazuto Kato). 2020, Tokyo.

Board of Directors of the Philosophical Society of Japan, Board of Trustees of the Japanese Society of Ethics, and Board of Directors of the Japanese Association for Religion. Statement on the Birth of Children by Genome Editing. 2018, Tokyo.

Science Council of Japan, Committee of Scientists, Subcommittee on Genome Editing Technology. Legal Regulations for the Clinical Application of Genome Editing Technology to Human Embryos, etc. 2020, Tokyo.

Japan Ministry of Health, Labor, and Welfare. Guidelines for Gene Therapy and Other Clinical Research. 2019, Tokyo.

Japan Society of Obstetrics and Gynaecology. Opinion on in vitro Fertilisation and Embryo Transfer. 2018, Tokyo.

Summary of Discussions. Expert Committee on the Clinical Use of Human Fertilised Embryos Using Genome Editing Technology, Science and Technology Subcommittee of the Health Sciences Council, 2020, Tokyo.

Doudna J, Sternberg S, Sakurai Y, et al., CRISPR - The Discovery of the Ultimate Gene Editing Technology. 2017, Bungei Shunju, Tokyo.

Baltimore D, Berg P, Botchan M, et al., 2015, A Prudent Path Forward for Genomic Engineering and Germline Gene Modification. Science, 348(6230): 36–38.

National Academy of Sciences. Human Genome Editing: Science, Ethics, and Governance. 2017, Washington.

National Academy of Sciences. Second International Summit on Human Genome Editing: Continuing the Global Discussion. Proceedings of a Workshop in Brief. 2019, Washington.

International Commission on the Clinical Use of Human Germline Genome Editing, viewed 27 August 2020, https://www.nationalacademies.org/our-work/international-commission-on-the-clinical-use-of-human-germline-genomeediting

Science Council of Japan, Committee on Genome Editing Technologies in the Medical and Pharmaceutical Fields. The State of Genome Editing Technology in the Medicine and Medical Fields in Japan. 2017, Tokyo.

International Bioethics Committee. Report of the IBC on Updating Its Reflection on the Human Genome and Human Rights. 2015, Paris.

World Health Organization (WHO). Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing, viewed 27 August 2020, https://www.who.int/ethics/topics/human-genomeediting/committee-members/en

World Health Organization (WHO). Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing - Call for Contributions, viewed 27 August 2020, https://www.who.int/ethics/topics/human-genome-editing/consultation-2020/en

World Health Organization (WHO). ICTRP, viewed 27 August 2020, https://www.who.int/ictrp/en

Takuma M. The 16th Task Force on the Review of the “Basic Approach to Handling Human Embryos”, February 25, 2019: Issues in the Use of Genome Editing Technology for Human Embryos Revealed from Dialogue with the Public, viewed 27 August 2020.

Jasanoff S, Hurlbut JB, Saha K, 2015, CRISPR Democracy: Gene Editing and the Need for Inclusive Deliberation. Issues in Science and Technology, XXXII(1): 25–32.

Jananoff S, Hurlbut JB, 2018, A Global Observatory for Gene Editing. Nature, 555(7697): 435–437.

The Nuffield Council on Bioethics. Genome editing and Human Reproduction: Social and Ethical Issues. 2018, London.

Friedmann T, Jonlin EC, King NMP, et al., 2015, ASGCT and JSGT Joint Position Statement on Human Genomic Editing. Molecular Therapy, 23(8): 1282.

Lovell-Badge R, 2019, CRISPR Babies: A View from the Centre of the Storm. Development, 146(3): dev175778.

Zwart H, Nelis A, 2009, What is ELSA Genomics? Science & Society Series on Convergence Research. EMBO Reports, 10(6): 540–544.

Kato K. Research in Society: Freedom, Ethics and Governance. In The Researching University - What is Knowledge for?, Chapter 3. 2013, Iwanami Shoten, Tokyo.

Osaka University, Research Centre for Co-creation of Social Technology, viewed 27 August 2020, https://elsi.osaka-u.ac.jp

Downloads

Published

2020-12-31